The EU Innovative Health Initiative will soon open its doors for the latest round of applicants, with up to €40 million ($44m) available in funding for each project. But who is eligible to apply for the scheme, and where do the key opportunities for medtech lie?
The EU Innovative Health Initiative (IHI) has published details of 10 draft topics that are expected to be included in two upcoming calls for project proposals. For medical device and IVD manufacturers, and research organizations, some of these topics represent potential funding opportunities.
Companies that develop tools that can be used to predict, diagnose and treat people who have suffered from strokes will...
The ceramic device, designed to reduce complications, will be exclusively distributed by Zimmer Biomet and initially available in 30 hospitals, with broader European access expected by 2026.
Amendments to Germany’s – barely in force – health reform law will be decided after the summer break. The new DRGs payments plan and service groups will be reviewed, but critics fear for the law’s future.
Combination products are no longer fringe – they are the “new normal,” consultant Stephen O’Rourke told Medtech Insight. The EU has the expertise to handle the regulatory complexity, but only if connects the dots between silos. That’s the challenge, he said, and the opportunity.
A government-backed program is working on improving the ability to run dementia clinical trials in the UK, and access to trials for participants.
Luna Health has raised $23.6m in Series A funding to support regulatory submissions, clinical studies and manufacturing for its insulin patch pump.
Combination products are no longer fringe – they are the “new normal,” consultant Stephen O’Rourke told Medtech Insight. The EU has the expertise to handle the regulatory complexity, but only if connects the dots between silos. That’s the challenge, he said, and the opportunity.
The US FDA has cleared NeuroOne's OneRF trigeminal nerve ablation system for the treatment of trigeminal neuralgia. This minimally invasive method utilizes radio frequency energy to alleviate pain, offering an alternative to traditional medications and surgeries. A fall commercial launch is planned.
